Digital Library
Close Browse articles from a journal
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             18 results found
no title author magazine year volume issue page(s) type
1 Antibody-drug conjugates: Resurgent anticancer agents with multi-targeted therapeutic potential Ceci, Claudia

236 C p.
article
2 Challenges and opportunities in metastatic breast cancer treatments: Nano-drug combinations delivered preferentially to metastatic cells may enhance therapeutic response Yu, Jesse

236 C p.
article
3 Clozapine’s multiple cellular mechanisms: What do we know after more than fifty years? A systematic review and critical assessment of translational mechanisms relevant for innovative strategies in treatment-resistant schizophrenia de Bartolomeis, Andrea

236 C p.
article
4 Early-stage structure-based drug discovery for small GTPases by NMR spectroscopy Yin, Guowei

236 C p.
article
5 Editorial Board
236 C p.
article
6 Emerging role of an immunomodulatory protein secretoglobin 3A2 in human diseases Kimura, Shioko

236 C p.
article
7 Genetic alterations and oxidative stress in T cell lymphomas Kumar, Sushant

236 C p.
article
8 MicroRNAs in drug addiction: Current status and future perspectives Zhao, Yue

236 C p.
article
9 Myeloperoxidase: Growing importance in cancer pathogenesis and potential drug target Valadez-Cosmes, Paulina

236 C p.
article
10 New therapeutic horizons for plasma phospholipid transfer protein (PLTP): Targeting endotoxemia, infection and sepsis Gautier, Thomas

236 C p.
article
11 Oncolytic ImmunoViroTherapy: A long history of crosstalk between viruses and immune system for cancer treatment Feola, S.

236 C p.
article
12 Prognostic and predictive molecular biomarkers in advanced colorectal cancer Martelli, Valentino

236 C p.
article
13 “RB-reactivator screening” as a novel cell-based assay for discoveries of molecular targeting agents including the first-in-class MEK inhibitor trametinib (trade name: Mekinist) Sakai, Toshiyuki

236 C p.
article
14 Recent advances in clinical trials targeting the kynurenine pathway Pires, Ananda Staats

236 C p.
article
15 Targeting hedgehog signaling in pancreatic ductal adenocarcinoma Quatannens, Delphine

236 C p.
article
16 Targeting RAS in neuroblastoma: Is it possible? Lin, Lei

236 C p.
article
17 Targeting the NLRP3 inflammasome in cardiovascular diseases Toldo, Stefano

236 C p.
article
18 The immune modifying effects of chemotherapy and advances in chemo-immunotherapy Principe, Daniel R.

236 C p.
article
                             18 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands